688065 凯赛生物
2025/09 - 九个月2024/122023/122022/122021/12

盈利能力分析
净资产收益率 ROE (%)3.0974.3143.3155.1235.654
总资产报酬率 ROA (%)2.1222.5832.0003.2534.200
投入资产回报率 ROIC (%)2.8763.7012.9234.7055.449

边际利润分析
销售毛利率 (%)34.75431.24728.79435.24135.629
营业利润率 (%)19.91918.64721.48829.01530.605
息税前利润/营业总收入 (%)15.89112.98211.23116.42222.939
净利润/营业总收入 (%)16.61716.04519.32425.09726.804

收益指标分析
经营活动净收益/利润总额(%)118.867108.87384.925101.86395.545
价值变动净收益/利润总额(%)0.285-1.633-1.742-0.5332.251
营业外收支净额/利润总额(%)-0.700-0.647-1.196-1.7660.152

偿债能力分析
流动比率 (X)6.9392.5322.2205.9519.357
速动比率 (X)6.1632.1271.7904.8468.384
资产负债率 (%)9.50420.61021.55915.6459.334
带息债务/全部投入资本 (%)-0.38211.48710.8726.1254.177
股东权益/带息债务 (%)-25,718.959745.335791.0821,478.0542,232.662
股东权益/负债合计 (%)789.793293.516274.962392.567705.067
利息保障倍数 (X)-4.086-2.341-1.123-1.358-2.974

营运能力分析
应收账款周转天数 (天)30.42729.84753.94947.91134.077
存货周转天数 (天)200.480234.276363.485314.122231.920